AI assistant
Wockhardt Ltd — Regulatory Filings 2021
Jul 15, 2021
59231_rns_2021-07-15_3955242b-4311-428c-b0c1-444ef918bb7a.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
15[th] July, 2021
==> picture [167 x 46] intentionally omitted <==
BSE Limited National Stock Exchange of India Limited Corporate Relations Department Exchange Plaza P J Towers Bandra Kurla Complex Dalal Street Bandra (E) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 532300 NSE Symbol: WOCKPHARMA
Dear Sir/Madam,
Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform the Exchanges that a meeting of the Board of Directors of the Company will be held on 22[nd] July, 2021, inter-alia , to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30[th] June, 2021.
Further, pursuant to Company's code of conduct for regulating, monitoring, reporting trading by designated persons and as informed vide letter dated 30[th] June, 2021, the Trading window for dealing in the Shares of the Company has been closed from 1[st] July, 2021 and shall remain closed till 24[th] July, 2021. The Trading Window shall re-open with effect from 25[th] July, 2021.
Kindly take the above information on record.
Thanking you,
for Wockhardt Limited
==> picture [114 x 43] intentionally omitted <==
Gajanand Sahu Company Secretary
==> picture [106 x 46] intentionally omitted <==
==> picture [482 x 30] intentionally omitted <==